CAS Number: 396091-73-9
EC Number: 686-178-6
Molecular Weight: 1047.2
Chemical Formula: C₅₈H₆₆N₁₀O₉
IUPAC Name: [(3S,6S,9S,12R,15S,18S,20R)-9-(4-aminobutyl)-3-benzyl-12-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-phenyl-6-[(4-phenylmethoxyphenyl)methyl]-1,4,7,10,13,16-hexazabicyclo[16.3.0]henicosan-20-yl] N-(2-aminoethyl)carbamate
Purity: ≥98.0%
Titre (Assay): Titre (assay) de pasireotide déterminé par méthode pharmacopée HPLC/titrage, confirmant la conformité à la pureté déclarée
Profil d'impuretés: Substances apparentées et impuretés de procédé de pasireotide contrôlées dans les limites de la pharmacopée/ICH Q3A

Autres informations

Description supplémentaire:

Pasireotide (CAS 396091-73-9, molecular formula C58H66N10O9, molecular weight 1047.21) is a cyclic peptide supplied at ≥98.0% purity. Marketed by Novartis as Signifor (SOM230), it is an orphan-designated somatostatin analog approved in the US and Europe for Cushing's disease in patients who are ineligible for or have failed surgery, distinguished by roughly 40-fold greater affinity for somatostatin receptor 5 than other analogs in its class.